Therapy development for X-linked myotubular myopathy
Therapy development for X-linked myotubular myopathy
批准号:
478411
负责人:
Dowling James
金额:
$69.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2028-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
X-linked myotubular myopathy (XLMTM) is a severe childhood muscle disease associated with wheelchair and ventilator dependence and early death, with few affected children living to adulthood. The disease is caused by mutations in a gene named myotubularin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of SPEG (Striated muscle preferentially expressed protein kinase) in skeletal muscle development and human muscle disease
-
批准号:462458
-
项目类别:Operating Grants
-
资助金额:$66.88万
-
财政年份:2022
-
负责人:Dowling James
-
依托单位:
Therapy development for X-linked myotubular myopathy
-
批准号:477257
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Dowling James
-
依托单位:
Novel therapies for neuromuscular diseases with altered phosphoinositide metabolism
-
批准号:367426
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2017
-
负责人:Dowling James
-
依托单位:
Unraveling the genetics of malignant hyperthermia
-
批准号:343736
-
项目类别:Operating Grants
-
资助金额:$69.62万
-
财政年份:2016
-
负责人:Dowling James
-
依托单位:
Therapy development for myotubular myopathy and related disorders
-
批准号:356564
-
项目类别:Operating Grants
-
资助金额:$55.73万
-
财政年份:2016
-
负责人:Dowling James
-
依托单位:
TAM4MTM: Tamoxifen therapy for myotubular myopathy
-
批准号:350583
-
项目类别:Operating Grants
-
资助金额:$8.52万
-
财政年份:2016
-
负责人:Dowling James
-
依托单位:
Regulators of PI3P metabolism in skeletal muscle development and as modifiers of myotubular myopathy.
-
批准号:304703
-
项目类别:Operating Grants
-
资助金额:$33.66万
-
财政年份:2014
-
负责人:Dowling James
-
依托单位:
海外基金